Thursday, January 29, 2009 11:03:05 AM
Personalized Medicine on Friday's Mad Money...
http://www.cnbc.com/id/28813740
Excerpt: "Personalized medicine uses everything from height and weight to gene and gene-expression information to treat patients. Celera and Abbott are trying to develop molecular diagnostic products to aid in the process. The two firms recently updated their deal, which should lower Celera’s operating expenses and give the company room to launch products outside the joint venture with Abbott. So even if a merger never happens, Celera might stand on its own as a solid investment."
More here:
http://www.madmoneyrecap.com/madmoney_nightlyrecap_012309_2.htm
Excerpt: "... personalized medicine requires a lot of diagnostic tests... and that is what Celera is working on with Abbott Labs... disease detection, assessing an individuals pre-disposition to certain diseases... monitoring the progression of a disease… and choosing the right therapy…. remember President Obama loves this stuff... because it saves money on health care costs down the line..."
http://www.dnaprint.com/welcome/corporate/
http://www.dnaprint.com/welcome/pipeline/
Daniel
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM